Cargando…
Analysis of FGFR3 and HRAS genes in patients with bladder cancer
Background: Bladder cancer is the most frequent malignancy that affects the urinary tract. Studies have shown different types of FGFR3 and HRAS genes mutations in human bladder cancer, with a comprehensive range of mutation number in various populations. This study aimed to determine the specific po...
Autores principales: | Homami, Ameneh, Ataei Kachoei, Zohreh, Asgarie, Mojgan, Ghazi, Farideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722963/ https://www.ncbi.nlm.nih.gov/pubmed/33316010 http://dx.doi.org/10.34171/mjiri.34.108 |
Ejemplares similares
-
Analysis of KRT5 and KRT14 gene mutations and mode of inheritance in Iranian patients with clinical suspicion of Epidermolysis bullosa simplex
por: Khani, Pouria, et al.
Publicado: (2020) -
MicroRNAs as biomarkers associated with bladder cancer
por: Homami, Amene, et al.
Publicado: (2016) -
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010) -
Analysis of PTEN in two BRCA1 and BRCA2 wild-type familial breast cancer patients
por: Akouchekian, Mansoureh, et al.
Publicado: (2015) -
Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors
por: Goriely, Anne, et al.
Publicado: (2009)